The Effect of Docosahexaenoic Acid Supplementation on Biomarkers of Concussion Over the Course of a Year in Canadian National Rugby Players
| Status: | Active, not recruiting |
|---|---|
| Conditions: | Hospital |
| Therapuetic Areas: | Other |
| Healthy: | No |
| Age Range: | Any |
| Updated: | 7/29/2018 |
| Start Date: | August 1, 2017 |
| End Date: | August 1, 2019 |
Nutrition interventions may present a safe and relatively risk free intervention for
protection against subconcussive impacts. Docosahexaenoic acid (DHA, 22:6n-3) is the
principal Omega 3 polyunsaturated fatty acid in the brain, playing an integral role in the
brain's development and structural integrity. The goal of this study is to determine if
supplementation with DHA attenuates blood biomarkers of repetitive head trauma linked to
sub-concussive impacts sustained in rugby participation.
protection against subconcussive impacts. Docosahexaenoic acid (DHA, 22:6n-3) is the
principal Omega 3 polyunsaturated fatty acid in the brain, playing an integral role in the
brain's development and structural integrity. The goal of this study is to determine if
supplementation with DHA attenuates blood biomarkers of repetitive head trauma linked to
sub-concussive impacts sustained in rugby participation.
Inclusion Criteria:
- Canadian national rugby athletes on 7s and 15s teams
Exclusion Criteria:
We found this trial at
1
site
Click here to add this to my saved trials
